New Delhi, April 1 Marksans Pharma Ltd announced on Wednesday that it has received final approval from the US health regulator for its generic version of Benzonatate capsules, indicated for the treatment of persistent cough, bronchitis, pneumonia, or other lung infections.The approval from the...
abbreviated new drug application (anda)
benzonatate
bioequivalence
bronchitis treatment
cough treatment
generic drug approval
lung infections
marksans pharma
non-narcotic antitussive
pfizer inc.
pharmaceutical industry
pneumonia treatment
tessaloncapsules
therapeutic equivalence
us food and drug administration (usfda)
